Prevention of Pressure Ulcers in Patients at Medium to High Risk of Developing Pressure Ulcers and Using the DOMUS 4 / AUTO Motorized Air Mattress

July 23, 2022 updated by: Wellell France

Prevention of Pressure Ulcers in Patients at Medium to High Risk of Developing Pressure Ulcers and Using the DOMUS 4 / AUTO Motorized Air Mattress: Non-interventional Study

The aim of the study is to determine the clinical value of using a powered alternating pressure air mattress (P-APAM) in the prevention of pressure injury (PI) in patients at medium to high risk.

This study is noncomparative, observational study.

Patients older than 18 years of age, with a medium to high risk of PI, without PI, up during the day, and lying more than 15 hours a day on a specific P-APAM were included. The study was conducted in nursing homes, and in long-stay geriatrics department.

Patients are followed up for 35 days. The use of the P-APAM is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who developed between day 0 and day 35 at least one PI of at least stage 2 on the sacrum, spine, or heel. Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

86

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Abondant, France
        • Ehpad Du Parc Chateau D'Abondant
      • Bauge En Anjou, France
        • Ehpad Esbv
      • Fontenay-aux-Roses, France
        • Ehpad Residence Le Parc
      • Saint-Jean-d'Illac, France
        • Ehpad Duc de Lorge
      • Saint-Parres-aux-Tertres, France
        • Ehpad Villa Du Tertre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients in nursing homes or long-stay geriatrics department

Description

Inclusion Criteria:

Patient over 18 years old

  • Patient with a medium to high risk of developing pressure ulcers (clinical judgment and a score of [10 to 14] on the Braden scale (6 (maximum risk) to 23 (no risk))
  • Patient without pressure injury on the day of inclusion
  • Patient up during the day, lying between 3 p.m. and 8 p.m. a day on a Domus 4 / AUTO mattress
  • Patient with a weight < 200 kg
  • Patient (or a trusted third party) having been informed of the study and agreeing to participate

Exclusion Criteria:

  • Patient at end of life (estimated life expectancy less than 6 months)
  • Malnourished patient according to the french health authority (Haute Autorité de la santé) definition*

    * For adults under 70:

    • weight loss ≥ 5% in one month or ≥ 10% in six months
    • or body mass index (BMI) ≤ 18.5 (excluding constitutional thinness)
  • for adults over 70:

    • weight loss ≥ 5% in one month or ≥ 10% in six months
    • or BMI ≤ 21
    • or Mini Nutritional Assessment (MNA) ≤ 17 (/30)
    • or albuminemia < 35 g/L

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of patients who developed at least one stage 2 pressure injury
Time Frame: 35 days after installation on the mattress (at day 35)
Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)
35 days after installation on the mattress (at day 35)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between
Time Frame: 35 days after installation on the mattress (at day 35)
35 days after installation on the mattress (at day 35)
Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)
Time Frame: 35 days after installation on the mattress (at day 35)
On a scale from 0 (not satisfied at all) to 4 (very satisfied)
35 days after installation on the mattress (at day 35)
Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)
Time Frame: 35 days after installation on the mattress (at day 35)
On a scale from 0 (not satisfied at all) to 4 (very satisfied)
35 days after installation on the mattress (at day 35)
Assessment of the degree of maceration
Time Frame: 35 days after installation on the mattress (at day 35)
On a scale from 1 (constantly moist) to 4 rarely moist
35 days after installation on the mattress (at day 35)
Assessment of mattress safety
Time Frame: At day 35
by collecting any adverse event or mattress malfunction during the follow up
At day 35

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Sylvie MEAUME, Pr, Hôpital Rotschild

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 17, 2018

Primary Completion (ACTUAL)

July 22, 2019

Study Completion (ACTUAL)

July 22, 2019

Study Registration Dates

First Submitted

July 21, 2022

First Submitted That Met QC Criteria

July 21, 2022

First Posted (ACTUAL)

July 25, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 23, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-A01274-51

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pressure Injury

Clinical Trials on Use of a powered alternating pressure air mattress

Subscribe